293 related articles for article (PubMed ID: 8242543)
1. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer.
Yan ZP; Lin G; Zhao HY; Dong YH
Cancer; 1993 Dec; 72(11):3210-5. PubMed ID: 8242543
[TBL] [Abstract][Full Text] [Related]
2. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
Andrews JC; Walker SC; Ackermann RJ; Cotton LA; Ensminger WD; Shapiro B
J Nucl Med; 1994 Oct; 35(10):1637-44. PubMed ID: 7931662
[TBL] [Abstract][Full Text] [Related]
3. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
4. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres.
Houle S; Yip TK; Shepherd FA; Rotstein LE; Sniderman KW; Theis E; Cawthorn RH; Richmond-Cox K
Radiology; 1989 Sep; 172(3):857-60. PubMed ID: 2549567
[TBL] [Abstract][Full Text] [Related]
6. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 glass microspheres injected via the portal vein. An experimental study.
Yan ZP; Lin G; Zhao HY; Dong YH
Acta Radiol; 1993 Jul; 34(4):395-8. PubMed ID: 8318305
[TBL] [Abstract][Full Text] [Related]
8. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA
Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837
[TBL] [Abstract][Full Text] [Related]
9. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.
Shepherd FA; Rotstein LE; Houle S; Yip TC; Paul K; Sniderman KW
Cancer; 1992 Nov; 70(9):2250-4. PubMed ID: 1327493
[TBL] [Abstract][Full Text] [Related]
10. Glass yttrium-90 microspheres for patients with colorectal liver metastases.
Anderson JH; Goldberg JA; Bessent RG; Kerr DJ; McKillop JH; Stewart I; Cooke TG; McArdle CS
Radiother Oncol; 1992 Oct; 25(2):137-9. PubMed ID: 1438931
[TBL] [Abstract][Full Text] [Related]
11. (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.
Camacho JC; Moncayo V; Kokabi N; Reavey HE; Galt JR; Yamada K; Kies DD; Williams RS; Kim HS; Schuster DM
Radiographics; 2015; 35(5):1602-18. PubMed ID: 26230755
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
Geschwind JF; Salem R; Carr BI; Soulen MC; Thurston KG; Goin KA; Van Buskirk M; Roberts CA; Goin JE
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S194-205. PubMed ID: 15508085
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of 90Y microspheres.
Ehrhardt GJ; Day DE
Int J Rad Appl Instrum B; 1987; 14(3):233-42. PubMed ID: 3667306
[TBL] [Abstract][Full Text] [Related]
14. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):205-13. PubMed ID: 15713921
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
16. Selective internal radiation therapy: distribution of radiation in the liver.
Burton MA; Gray BN; Klemp PF; Kelleher DK; Hardy N
Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1487-91. PubMed ID: 2591440
[TBL] [Abstract][Full Text] [Related]
17. The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.
Walrand S; Hesse M; Chiesa C; Lhommel R; Jamar F
J Nucl Med; 2014 Jan; 55(1):135-40. PubMed ID: 24296766
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
19. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
20. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
